Glandin E-2 Vag 3mg Tablets is primarily indicated in conditions like Abortion, Hydatidiform mole, Labor induction, Uterine atonia.
The severe or irreversible adverse effects ofGlandin E-2 Vag 3mg Tablets, which give rise to further complications include Severe pain, Acute fetal distress.,Dinoprostone produces potentially life-threatening effects which include Cardiogenic collapse. which are responsible for the discontinuation ofGlandin E-2 Vag 3mg Tablets therapy.,The signs and symptoms that are produced after the acute overdosage ofGlandin E-2 Vag 3mg Tablets include Uterine hypertonus.,The symptomatic adverse reactions produced byGlandin E-2 Vag 3mg Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Vomiting, Diarrhea, Erythema, Flushing, Syncope, Vaginal burning, Pallor, Transient pyrexia.
Dinoprostone is contraindicated in conditions like Asthma, Glucoma, Hepatic disease,Pulmonary disease, Pelvic inflammatory disease.
Dinoprostone should be used with caution in patients with medical history, including any allergy (especially drug allergy), pelvic infections, heart, lungs, kidney or liver diseases, high or low blood pressure, anemia, cervicitis, diabetes mellitus, acute vaginitis, infected endocervical lesions, compromised uterus, or a history of asthma, hypertension, hypotension, epilepsy or other seizure disorder, or jaundice. It should not be used at term if patient have a history of caesarean section or major surgery, in patient with vasa previa or who have had unexplained vaginal bleeding during their course of pregnancy. It should not be used in case of abnormal fetal position, cephalopelvic disproportion or signs of fetal distress. Maternal problems such as a history of difficult labor or traumatic delivery, grand multiparity, or any hyperactive or hypertonic uterine patterns indicate thatGlandin E-2 Vag 3mg Tablets should not be used.